HopeStage
Back to all studies
SuspendedNCT03674671

Ketamine Versus Electroconvulsive Therapy in Depression

Researchers are comparing Intravenous Ketamine and electroconvulsive therapy to find out how the approaches affect depression symptoms in people with depression.

Medication studyAges 18–70Canada
The study in practice

Understand this study

What is this study about?

Researchers are comparing Intravenous Ketamine and electroconvulsive therapy to find out how the approaches affect depression symptoms in people with depression.

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
Kingston and 3 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 29, 2018
Recruitment status
Suspended
Enrollment listed in the registry
240
Sponsor
University of Ottawa
Sponsor type
University
Study type
Drug
Intervention type
Drug, Procedure
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
From 18 Years to 70 Years
Official registry ID
NCT03674671
Official title
Show the full official title

Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy

Recruitment & locations

Suspended

Kingston · Ottawa · Toronto

1 more locations
  • Whitby

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

Researchers are comparing Intravenous Ketamine and electroconvulsive therapy to find out how the approaches affect depression symptoms in people with depression.

Who is behind this study?

The study sponsor is University of Ottawa, a university.

Does this study involve medication?

Yes. The study involves medication, including Intravenous Ketamine.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies